Citations 2
P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME- THE MAYO CLINIC EXPERIENCE
Lacy, M. , Fonder, Amie , Hobbs, Miriam, Hayman, S. R., hwa, L. Y., Kouralis, T., Warsame, Rahma , Nelson, Lauren Juliette Hassan, Kapoor, Prashant , Grogan, Martha , Siddiqi, Mustaqeem A, Robert, K., Vaxman, Iuliana , Kumar, Subodh , Buadi, Francis K. , Dingli, David , Muchtar, Eli , Go, Ronald S. , Gonsalves, Wilson I. , Rajkumar, S. Vincent , Gertz, Morie A. , Dispenzieri, Angela
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 856-857
Gene expression signatures of conventional prognostic factors in multiple myeloma
Haug, Janine , Shammas, Masood A. , Lacy, Martha Q. , Munshi, Nikhil C. , Kumar, Subodh , Rajkumar, S. Vincent , Li, Chaofan , Dispenzieri, Angela , Gertz, Morie A. , Witzig, Thomas E. , Anderson, Kenneth C.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 6606-6606